UltraSPECT recommends alternative protocols for dose-reduction

UltraSPECT, based in Haifa, Israel, has issued three different dose-reduction protocol recommendations for using its image reconstruction products--Xpress.Cardiac and Xpress3.

According to the company, Xpress.Cardiac and Xpress3 allow lower dose imaging protocols with no compromise in imaging and support most existing camera hardware and workstation versions.

UltraSPECT offers one-day rest/stress protocol with the Xpress.Cardiac, with scan times as defined by the American Society of Nuclear Cardiology (ASNC) recommendations, but with injected doses that are approximately half the doses specified by ASNC. Ultraspect also offers two different protocols with the Xpress3.Cardiac for single day rest/stress protocol or the dual-isotope single-day protocol.

Around the web

Richard Heller III, MD, RSNA board member and senior VP of policy at Radiology Partners, offers an overview of policies in Congress that are directly impacting imaging.
 

The two companies aim to improve patient access to high-quality MRI scans by combining their artificial intelligence capabilities.

Positron, a New York-based nuclear imaging company, will now provide Upbeat Cardiology Solutions with advanced PET/CT systems and services.